SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.960
+0.340 (9.39%)
At close: May 13, 2026, 4:00 PM EDT
3.900
-0.060 (-1.52%)
After-hours: May 13, 2026, 6:54 PM EDT
SAB Biotherapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$11.80
Upside
+197.98%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +152.53% | May 12, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +228.28% | May 11, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +228.28% | Apr 2, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $14 | Strong Buy | Maintains | $12 → $14 | +253.54% | Mar 11, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +76.77% | Mar 10, 2026 |
| UBS | UBS | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +76.77% | Jan 7, 2026 |
| Guggenheim | Guggenheim | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +278.79% | Dec 19, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +203.03% | Dec 18, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +203.03% | Nov 17, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +203.03% | Sep 19, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 → $12 | Strong Buy | Maintains | $20 → $12 | +203.03% | Aug 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +127.27% | Jul 22, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +405.05% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +152.53% | May 14, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 → $20 | Strong Buy | Maintains | $25 → $20 | +405.05% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +51.52% | Apr 1, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.